News

Medical Dialogues43m
GLP-1 Receptor Agonists Use Linked to Lower Cardiovascular Risk in Diabetic Patients with MGUS: Study
USA: A recent study published in JAMA Network Open has found that the use of glucagon-like peptide-1 (GLP-1) receptor ...
Dr. Reddy’s US generics business drags Q1 earnings, eyes weight-loss drug launch in 87 countries
The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...